Effect of methotrexate on alveolar bone loss in experimental periodontitis in Wistar rats

References

• Kinane DF. Causation and pathogenesis of periodontal disease. Periodontol 2000 2001; 25: 8–20
   PubMed Web of Science ®Google Scholar
• Madianos PN, Bobetsis YA, Kinane DF. Generation of inflammatory stimuli: How bacteria set up inflammatory responses in the gingiva. J Clin Periodontol 2005; 32 Suppl 6: 57–71
   PubMed Web of Science ®Google Scholar
• Page RC. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res 1991; 26: 230–42
   PubMed Web of Science ®Google Scholar
• Graves DT, Delima AJ, Assuma R, Amar S, Oates T, Cochran D. Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis. J Periodontol 1998; 69: 1419–25
   PubMed Web of Science ®Google Scholar
• Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003; 74: 391–401
   PubMed Web of Science ®Google Scholar
• Stashenko P, Jandinski JJ, Fujiyoshi P, Rynar J, Socransky S. Tissue levels of bone resorptive cytokines in periodontal disease. J Periodontol 1991; 62: 504–9
   PubMed Web of Science ®Google Scholar
• Tervahartiala T, Koski H, Xu JW, Häyrinen-Immonen R, Hietanen J, Sorsa T, et al. Tumor necrosis factor-α and its receptors, p55 and p75, in gingiva of adult periodontitis. J Dent Res 2001; 80: 1535–9
   PubMed Web of Science ®Google Scholar
• Figueredo CM, Ribeiro MS, Fischer RG, Gustafsson A. Increased interleukin-1beta concentration in gingival crevicular fluid as a characteristic of periodontitis. J Periodontol 1999; 70: 1457–63
   Google Scholar
• Koide M, Suda S, Saitoh S, Ofuji Y, Suzuki T, Yoshie H, et al. In vivo administration of IL-1 beta accelerates silk ligature-induced alveolar bone resorption in rats. J Oral Pathol Med 1995; 24: 420–34
   PubMed Web of Science ®Google Scholar
• Gaspersic R, Stiblar-Martincic D, Osredkar J, Skaleric U. Influence of subcutaneous administration of recombinant TNF-alpha on ligature-induced periodontitis in rats. J Periodontal Res 2003; 38: 198–203
   PubMed Web of Science ®Google Scholar
• Assuma R, Oates T, Cochran D, Amar S, Graves DT. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol 1998; 160: 403–9
   PubMed Web of Science ®Google Scholar
• Oates TW, Graves DT, Cochran DL. Clinical, radiographic and biochemical assessment of IL-1/TNF-alpha antagonist inhibition of bone loss in experimental periodontitis. J Clin Periodontol 2002; 29: 137–43
   PubMedGoogle Scholar
• de Lima V, Bezerra MM, de Menezes Alencar VB, Vidal FD, da Rocha FA, de Castro Brito GA, et al. Effects of chlorpromazine on alveolar bone loss in experimental periodontal disease in rats. Eur J Oral Sci 2000; 108: 123–9
   PubMed Web of Science ®Google Scholar
• Lima V, Vidal FD, Rocha FA, Brito GA, Ribeiro RA. Effects of tumor necrosis factor-alpha inhibitors pentoxifylline and thalidomide on alveolar bone loss in short-term experimental periodontal disease in rats. J Periodontol 2004; 75: 162–8
   PubMed Web of Science ®Google Scholar
• Cronstein BN. Molecular therapeutics. Methotrexate and its mechanism of action. Arthritis Rheum 1996; 39: 1951–60
   PubMed Web of Science ®Google Scholar
• Cutolo M, Bisso A, Sulli A, Felli L, Briata M, Pizzorni C, et al. Antiproliferative and antiinflammatory effects of methotrexate on cultured differentiating myeloid monocytic cells (THP-1) but not on synovial macrophages from patients with rheumatoid arthritis. J Rheumatol 2000; 27: 2551–7
   PubMed Web of Science ®Google Scholar
• Cutolo M, Sulli A, Pizzorni C, Seriolo B, Straub RH. Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis. Ann Rheum Dis 2001; 60: 729–35
   PubMed Web of Science ®Google Scholar
• Yoshinari N, Kameyama Y, Aoyama Y, Nishiyama H, Noguchi T. Effect of long-term methotrexate-induced neutropenia on experimental periodontal lesion in rats. J Periodontal Res 1994; 29: 393–400
   PubMedGoogle Scholar
• Grove ML, Hassell AB, Hay EM, Shadforth MF. Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice. QJM 2001; 94: 309–19
   PubMedGoogle Scholar
• Björnsson MJ, Velschow S, Stoltze K, Havemose-Poulsen A, Schou S, Holmstrup P. The influence of diet consistence, drinking water and bedding on periodontal disease in Sprague-Dawley rats. J Periodontal Res 2003; 38: 543–50
   PubMedGoogle Scholar
• Cegiela U, Sliwinski L, Kaczmarczyk-Sedlak I, Folwarczna J. In vivo effects of high-dose methotrexate on bone remodeling in rats. Pharmacol Rep 2005; 57: 504–14
   PubMed Web of Science ®Google Scholar
• Sakuma S, Nishigaki F, Magari K, Ogawa T, Miyata S, Ohkubo Y, et al. FK506 is superior to methotrexate in therapeutic effects on advanced stage of rat adjuvant-induced arthritis. Inflamm Res 2001; 50: 509–14
   PubMed Web of Science ®Google Scholar
• Susin C, Rösing CK. Effect of variable moderate chronic stress on ligature-induced periodontal disease in Wistar rats. Acta Odontol Scand 2003; 61: 273–7
   PubMed Web of Science ®Google Scholar
• Cavagni J, Soletti AC, Gaio EJ, Rösing CK. The effect of dexamethasone in the pathogenesis of ligature-induced periodontal disease in Wistar rats. Braz Oral Res 2005; 19: 290–4
   PubMedGoogle Scholar
• Grauballe MC, Bentzen BH, Björnsson M, Moe D, Jonassen TE, Bendtzen K, et al. The effect of spironolactone on experimental periodontitis in rats. J Periodontal Res 2005; 40: 212–17
   PubMedGoogle Scholar
• Sacket D. Evidence-based medicine: How to practice and teach EBM. Churchill Livingtone, New York 2000
   Google Scholar